Phenotypic and Molecular Characterization of a Hospital Outbreak Clonal Lineage of Salmonella enterica Subspecies enterica serovar Mikawasima Containing blaTEM-1B and blaSHV-2 That Emerged on a Neonatal Ward, During the COVID-19 Pandemic.

IF 2.3 4区 医学 Q3 INFECTIOUS DISEASES Microbial drug resistance Pub Date : 2024-03-01 Epub Date: 2024-02-07 DOI:10.1089/mdr.2023.0132
Anita Novak, Mia Dzelalija, Ivana Goic-Barisic, Ana Kovacic, Mario Pirija, Ana Maravic, Marina Radic, Jelena Marinovic, Zana Rubic, Merica Carev, Marija Tonkic
{"title":"Phenotypic and Molecular Characterization of a Hospital Outbreak Clonal Lineage of <i>Salmonella enterica</i> Subspecies <i>enterica</i> serovar Mikawasima Containing <i>bla</i><sub>TEM-1B</sub> and <i>bla</i><sub>SHV-2</sub> That Emerged on a Neonatal Ward, During the COVID-19 Pandemic.","authors":"Anita Novak, Mia Dzelalija, Ivana Goic-Barisic, Ana Kovacic, Mario Pirija, Ana Maravic, Marina Radic, Jelena Marinovic, Zana Rubic, Merica Carev, Marija Tonkic","doi":"10.1089/mdr.2023.0132","DOIUrl":null,"url":null,"abstract":"<p><p>Nontyphoid salmonella can cause severe infections in newborns and is therefore declared a pathogen of major health significance at this age. The aim of the study was molecular and antimicrobial characterization of β-lactamase-producing <i>Salmonella</i> Mikawasima outbreak clone on a Neonatal ward, University Hospital of Split (UHS), Croatia during the COVID-19 pandemic. From April 2020, until April 2023, 75 nonrepetitive strains of <i>Salmonella</i> Mikawasima were isolated from stool specimens and tested for antimicrobial resistance. All 75 isolates were resistant to ampicillin and gentamicin, while 98% of isolates were resistant to amoxicillin/clavulanic acid. A high level of resistance was observed to third-generation cephalosporins (36% to ceftriaxone and 47% to ceftazidime). Extended-spectrum β-lactamase production was phenotypically detected by double-disk synergy test in 40% of isolates. Moderate resistance to quinolones was detected; 7% of isolates were resistant to pefloxacin and ciprofloxacin. All isolates were susceptible to carbapenems, chloramphenicol, and co-trimoxazole. Fourteen representative isolates, from 2020, 2021, 2022, and 2023, were analyzed with PFGE and all of them belong to the same clone. Whole-genome sequencing (WGS) analysis of three outbreak-related strains (SM1 and SM2 from 2020 and SM3 from 2023) confirmed that these strains share the same serotype (Mikawasima), multilocus sequence typing profile (ST2030), resistance genes [<i>bla</i><sub>TEM-1B,</sub> <i>aac(6')-Iaa, aac(6')-Im,</i> and <i>aph(2'')-Ib)</i>] and carry incompatibility group C (IncC) plasmid. Furthermore, the gene <i>bla</i><sub>SHV-2</sub> was detected in SM1 and SM2. In summary, WGS analysis of three representative strains clearly demonstrates the persistence of β-lactamase-producing <i>Salmonella</i> Mikawasima in UHS during the 4-year period.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"118-126"},"PeriodicalIF":2.3000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial drug resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/mdr.2023.0132","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/7 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Nontyphoid salmonella can cause severe infections in newborns and is therefore declared a pathogen of major health significance at this age. The aim of the study was molecular and antimicrobial characterization of β-lactamase-producing Salmonella Mikawasima outbreak clone on a Neonatal ward, University Hospital of Split (UHS), Croatia during the COVID-19 pandemic. From April 2020, until April 2023, 75 nonrepetitive strains of Salmonella Mikawasima were isolated from stool specimens and tested for antimicrobial resistance. All 75 isolates were resistant to ampicillin and gentamicin, while 98% of isolates were resistant to amoxicillin/clavulanic acid. A high level of resistance was observed to third-generation cephalosporins (36% to ceftriaxone and 47% to ceftazidime). Extended-spectrum β-lactamase production was phenotypically detected by double-disk synergy test in 40% of isolates. Moderate resistance to quinolones was detected; 7% of isolates were resistant to pefloxacin and ciprofloxacin. All isolates were susceptible to carbapenems, chloramphenicol, and co-trimoxazole. Fourteen representative isolates, from 2020, 2021, 2022, and 2023, were analyzed with PFGE and all of them belong to the same clone. Whole-genome sequencing (WGS) analysis of three outbreak-related strains (SM1 and SM2 from 2020 and SM3 from 2023) confirmed that these strains share the same serotype (Mikawasima), multilocus sequence typing profile (ST2030), resistance genes [blaTEM-1B, aac(6')-Iaa, aac(6')-Im, and aph(2'')-Ib)] and carry incompatibility group C (IncC) plasmid. Furthermore, the gene blaSHV-2 was detected in SM1 and SM2. In summary, WGS analysis of three representative strains clearly demonstrates the persistence of β-lactamase-producing Salmonella Mikawasima in UHS during the 4-year period.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19 大流行期间在新生儿病房出现的含有 blaTEM-1B 和 blaSHV-2 的肠炎沙门氏菌亚种肠炎血清 Mikawasima 的医院爆发克隆系的表型和分子特征。
非伤寒沙门氏菌可导致新生儿严重感染,因此被认为是对新生儿健康具有重要意义的病原体。本研究的目的是对 COVID-19 大流行期间克罗地亚斯普利特大学医院(UHS)新生儿病房暴发的产β-内酰胺酶沙门氏菌 Mikawasima 克隆菌进行分子和抗菌鉴定。从 2020 年 4 月到 2023 年 4 月,从粪便标本中分离出 75 株不重复的 Mikawasima 沙门氏菌,并进行了抗菌药耐药性检测。所有 75 株分离菌株均对氨苄西林和庆大霉素产生耐药性,98% 的分离菌株对阿莫西林/克拉维酸产生耐药性。对第三代头孢菌素的耐药率较高(头孢曲松为 36%,头孢他啶为 47%)。通过双盘协同试验,40%的分离菌株产生了广谱β-内酰胺酶。检测到对喹诺酮类药物有中度耐药性;7% 的分离株对培氟沙星和环丙沙星有耐药性。所有分离株都对碳青霉烯类、氯霉素和共三唑类药物敏感。对来自 2020 年、2021 年、2022 年和 2023 年的 14 个代表性分离株进行了 PFGE 分析,它们都属于同一个克隆。对三株与疫情相关的菌株(2020 年的 SM1 和 SM2 以及 2023 年的 SM3)进行的全基因组测序(WGS)分析证实,这些菌株具有相同的血清型(Mikawasima)、多焦点序列分型特征(ST2030)、抗性基因[blaTEM-1B、aac(6')-Iaa、aac(6')-Im 和 aph(2'')-Ib] 并携带不相容组 C(IncC)质粒。此外,在 SM1 和 SM2 中还检测到 blaSHV-2 基因。总之,对三株代表性菌株的 WGS 分析清楚地表明,产β-内酰胺酶沙门氏菌 Mikawasima 在这四年中一直存在于 UHS 中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Microbial drug resistance
Microbial drug resistance 医学-传染病学
CiteScore
6.00
自引率
3.80%
发文量
118
审稿时长
6-12 weeks
期刊介绍: Microbial Drug Resistance (MDR) is an international, peer-reviewed journal that covers the global spread and threat of multi-drug resistant clones of major pathogens that are widely documented in hospitals and the scientific community. The Journal addresses the serious challenges of trying to decipher the molecular mechanisms of drug resistance. MDR provides a multidisciplinary forum for peer-reviewed original publications as well as topical reviews and special reports. MDR coverage includes: Molecular biology of resistance mechanisms Virulence genes and disease Molecular epidemiology Drug design Infection control.
期刊最新文献
In-Vitro Activity of Dimercaptosuccinic Acid in Combination with Carbapenems Against Carbapenem-Resistant Pseudomonas aeruginosa. A Selective Culture Medium for Screening Aztreonam-Avibactam Resistance in Enterobacterales and Pseudomonas aeruginosa. Deciphering the Resistome and Mobiolme of an Avian-Associated Enterococus faecalis ST249 Clone that Acquired Vancomycin Resistance Isolated from Neutropenic Patient in Tunisia. Spreading Ability of Tet(X)-Harboring Plasmid and Effect of Tetracyclines as a Selective Pressure. Emergence of Salmonella enterica Serovar Heidelberg Producing OXA 48 Carbapenemase in Eastern Algeria.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1